AIIMS

OPD Appointment

OPD Appointment

OPD Appointment

ORBO Donor Pledge Form

ORBO Donor Pledge Form

ORBO Donor Pledge Form

Emergency Dashboard

Emergency Dashboard

Emergency Dashboard

Accessibility Control

Parthaprasad Chattopadhyay

  1. Home
  2. Departments
  3. Parthaprasad Chattopadhyay
Breadcrumb Banner
Parthaprasad Chattopadhyay

Dr.
Parthaprasad Chattopadhyay

Affiliation

Professor
Department of
Biochemistry

Contact

Email :
parthoaiims@hotmail.com
Phone :
011-26549238

Additional Responsibility

Office Address

General OPD

Special Clinic

Surgery Days

Speciality of work

Areas of teaching

Areas of teaching

Address : Room No. 4007, Convergence Block, AIIMS, New Delhi.

EDUCATION

MBBS, (1981-1987) R G Kar Medical College, Calcutta University, Kolkata

MD, Biochemistry, (1989-1991) All India Institute of Medical Sciences, New Delhi.

PhD, Biochemistry (1992-1996) All India Institute of Medical Sciences, New Delhi.

PROFESSIONAL EXPERIENCE

Senior Demonstrator (1992-1995) Department of Biochemistry, AIIMS, New Delhi

Assistant Professor (1997-2003) Department of Biochemistry, AIIMS, New Delhi

Associate Professor (2003-2007) Department of Biochemistry, AIIMS, New Delhi

Additional Professor (2007-2011) Department of Biochemistry, AIIMS, New Delhi

Professor (2011- till date) Department of Biochemistry, AIIMS, New Delhi

Present Team

  • PhD Students
    • Neha Singh: Ritika Singh:
  • MD student: Dr. Abhishek Mishra

Research Focus of the Lab

a) Nanoparticle trafficking within the cell: Tracing the path of nanoparticles within the cell and attempting to modulate their intracellular travel to prolong their stay within the cell for increased unloading of their cargo (drug).

b) Site-directed epigenetic modulation: Using modified CRISPR based techniques to modulate CpG methylation and Histone methylation/acetylation for altering gene expression of tumor suppressor and promoter genes

Strategic publications

  • Passive internalization and active extrusion determines PLGA-nanoparticle concentration in cancer cell lines. Baidya G, Tiwary R, Mudassir M, Singh N, Saha S, Chosdol K, Sinha S, Chattopadhyay P..Nanomedicine (Lond). 2020 Aug;15(23):2229-2239.
  • HIF-2α mediates a marked increase in migration and stemness characteristics in a subset of glioma cells under hypoxia by activating an Oct-4/Sox-2-Mena (INV) axis. Bhagat M, Palanichamy JK, Ramalingam P, Mudassir M, Irshad K, Chosdol K, Sarkar C, Seth P, Goswami S, Sinha S, Chattopadhyay P..Int J Biochem Cell Biol. 2016 May;74:60-71.
  • A novel placental like alkaline phosphatase promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting. Khan I, Zakaria MK, Kumar M, Mani P, Chattopadhyay P, Sarkar DP, Sinha S..J Transl Med. 2015 Aug 5;13:254.
  • Gene Silencing and Activation of Human Papillomavirus 18 Is Modulated by Sense Promoter Associated RNA in Bidirectionally Transcribed Long Control Region. Kassab MA, Mudassir M, Singh A, Bhagat M, Palanichamy JK, Ramalingam P, Chosdol K, Sinha S, Chattopadhyay P..PLoS One. 2015 Jun 5;10(6):e0128416.
  • Biogenesis of intronic miRNAs located in clusters by independent transcription and alternative splicing. Ramalingam P, Palanichamy JK, Singh A, Das P, Bhagat M, Kassab MA, Sinha S, Chattopadhyay P. RNA. 2014 Jan;20(1):76-87.
  • Combination of hepatocyte specific delivery and transformation dependent expression of shRNA inducing transcriptional gene silencing of c-Myc promoter in hepatocellular carcinoma cells. Zakaria MK, Khan I, Mani P, Chattopadhyay P, Sarkar DP, Sinha S..BMC Cancer. 2014 Aug 10;14:582. doi: 10.1186/1471-2407-14-582.
  • Long-term suppression of HIV-1C virus production in human peripheral blood mononuclear cells by LTR heterochromatization with a short double-stranded RNA. Singh A, Palanichamy JK, Ramalingam P, Kassab MA, Bhagat M, Andrabi R, Luthra K, Sinha S, Chattopadhyay P..J Antimicrob Chemother. 2014 Feb;69(2):404-15.
  • CpG hypermethylation of the C-myc promoter by dsRNA results in growth suppression. Mehndiratta M, Palanichamy JK, Pal A, Bhagat M, Singh A, Sinha S, Chattopadhyay P..Mol Pharm. 2011 Dec 5;8(6):2302-9.
  • Silencing of integrated human papillomavirus-16 oncogenes by small interfering RNA-mediated heterochromatization.Palanichamy JK, Mehndiratta M, Bhagat M, Ramalingam P, Das B, Das P, Sinha S, Chattopadhyay P..Mol Cancer Ther. 2010 Jul;9(7):2114-22.
  • Aberrant methylation and associated transcriptional mobilization of Alu elements contributes to genomic instability in hypoxia. Pal A, Srivastava T, Sharma MK, Mehndiratta M, Das P, Sinha S, Chattopadhyay P..J Cell Mol Med. 2010 Nov;14(11):2646-54..

Funding Agencies

Department of Biotechnology and Department of Science & Technology, Ministry of Science & Technology, GOI.